Results 261 to 270 of about 8,346,626 (381)

Advanced Oral Delivery Systems for Nutraceuticals

open access: yesAdvanced Healthcare Materials, EarlyView.
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang   +4 more
wiley   +1 more source

Is public transport a promising strategy for increasing physical activity? Evidence from a study of objectively measured public transport use and physical activity. [PDF]

open access: yesInt J Behav Nutr Phys Act
Evans JT   +8 more
europepmc   +1 more source

COVID-19 incidence in a cohort of public transport workers. [PDF]

open access: yesMed Lav, 2022
De Matteis S   +3 more
europepmc   +1 more source

CLDN18.2 CAR‐derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer

open access: yesAdvanced Healthcare Materials, EarlyView.
CLDN18.2 CAR‐T cell‐derived small extracellular vesicles (CAR‐sEVs) display potent cytotoxicity and prolong survival in preclinical pancreatic cancer models. They contain functional CAR proteins and granzyme B, exhibit antigen specificity, and effectively target tumor cells while sparing healthy cells.
Yue Qing   +7 more
wiley   +1 more source

Public transport across models and scales: A case study of the Munich network. [PDF]

open access: yesPNAS Nexus
Mölter J   +7 more
europepmc   +1 more source

A model of the determination of the public transport lines in the public transport system

open access: yesIOP Conference Series: Materials Science and Engineering, 2019
A Boroiu, V Bratu
openaire   +2 more sources

Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response

open access: yesAdvanced Healthcare Materials, EarlyView.
In this paper, a novel nanoparticle scaffold composed of dendrimers conjugated with peptide‐based immune checkpoint inhibitors, enhancing drug delivery efficacy is introduced. By conjugating PD‐L1‐binding peptides to dendrimers, multivalent binding effects are harnessed, resulting in enhanced binding affinity, prolonged half‐life, and improved ...
DaWon Kim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy